PADRINI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.843
AS - Asia 3.984
EU - Europa 2.836
AF - Africa 1.071
SA - Sud America 969
OC - Oceania 113
Continente sconosciuto - Info sul continente non disponibili 46
Totale 19.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.306
SG - Singapore 1.437
CN - Cina 707
BR - Brasile 629
HK - Hong Kong 532
DE - Germania 324
VN - Vietnam 321
FI - Finlandia 304
IT - Italia 279
GB - Regno Unito 242
UA - Ucraina 198
FR - Francia 194
SE - Svezia 172
PL - Polonia 150
RU - Federazione Russa 108
NL - Olanda 74
IN - India 57
TR - Turchia 53
ZA - Sudafrica 51
AR - Argentina 46
EC - Ecuador 44
AO - Angola 41
GA - Gabon 41
PY - Paraguay 39
ID - Indonesia 38
KG - Kirghizistan 38
ME - Montenegro 38
MU - Mauritius 38
MX - Messico 38
PS - Palestinian Territory 38
RS - Serbia 38
UG - Uganda 38
ML - Mali 37
SA - Arabia Saudita 37
BE - Belgio 36
CV - Capo Verde 36
DK - Danimarca 36
IL - Israele 36
SN - Senegal 36
AT - Austria 35
BB - Barbados 35
CA - Canada 35
PE - Perù 35
VE - Venezuela 35
CO - Colombia 34
AL - Albania 33
BO - Bolivia 33
CH - Svizzera 33
CZ - Repubblica Ceca 33
MY - Malesia 33
UZ - Uzbekistan 33
BZ - Belize 32
CI - Costa d'Avorio 32
IE - Irlanda 32
JO - Giordania 32
JP - Giappone 32
PA - Panama 32
CW - ???statistics.table.value.countryCode.CW??? 31
HN - Honduras 31
LU - Lussemburgo 31
AE - Emirati Arabi Uniti 30
ES - Italia 30
GH - Ghana 30
IR - Iran 30
KR - Corea 30
LY - Libia 30
MG - Madagascar 30
MR - Mauritania 30
UY - Uruguay 30
HR - Croazia 29
IQ - Iraq 29
LC - Santa Lucia 29
MD - Moldavia 29
PK - Pakistan 29
GT - Guatemala 28
JM - Giamaica 28
MK - Macedonia 28
TN - Tunisia 28
AM - Armenia 27
AU - Australia 27
AZ - Azerbaigian 27
CR - Costa Rica 27
CU - Cuba 27
EE - Estonia 27
GN - Guinea 27
HU - Ungheria 27
MA - Marocco 27
PR - Porto Rico 27
TT - Trinidad e Tobago 27
BF - Burkina Faso 26
CM - Camerun 26
KE - Kenya 26
LV - Lettonia 26
RO - Romania 26
CL - Cile 25
DZ - Algeria 25
IS - Islanda 25
KZ - Kazakistan 25
MW - Malawi 25
RE - Reunion 25
Totale 18.703
Salva come PNG Salva come JPEG
Città #
Fairfield 1.360
Singapore 912
Woodbridge 892
Chandler 770
Jacksonville 746
Ashburn 729
Houston 704
Ann Arbor 646
Wilmington 552
Hong Kong 508
Seattle 491
Cambridge 487
Princeton 303
Santa Clara 275
Boardman 250
Beijing 189
Dong Ket 163
San Diego 133
Bytom 113
Nanjing 112
Helsinki 106
Des Moines 103
Medford 100
Roxbury 97
Padova 83
Munich 77
Los Angeles 69
Ho Chi Minh City 55
São Paulo 49
Chicago 41
Libreville 40
Kampala 38
Bamako 37
Dakar 36
Shenyang 35
Bridgetown 34
New York 34
Hanoi 33
Luanda 33
Praia 33
Bishkek 32
Guangzhou 32
Nanchang 32
Podgorica 32
Amman 30
Panama City 30
Abidjan 29
Castries 29
Tashkent 29
Norwalk 28
Nouakchott 27
Willemstad 27
Buffalo 26
Conakry 26
Lima 26
London 26
Antananarivo 25
Baku 25
Changsha 25
Montevideo 25
Havana 24
Accra 23
Dushanbe 23
Jiaxing 23
Vienna 23
Yerevan 23
Belo Horizonte 22
Dublin 22
Guatemala City 22
Lusaka 22
Nairobi 22
Niamey 22
Turku 22
Noumea 21
Ouagadougou 21
Riga 21
Warsaw 21
Harare 20
Hefei 20
Johannesburg 20
Tirana 20
Ulan Bator 20
Kingston 19
Managua 19
Maputo 19
Phnom Penh 19
Reykjavik 19
Tallinn 19
Asunción 18
Belize City 18
Cotonou 18
Gaborone 18
Kuala Lumpur 18
Minsk 18
Nassau 18
Tianjin 18
Addis Ababa 17
Auckland 17
Kigali 17
Kinshasa 17
Totale 12.832
Salva come PNG Salva come JPEG
Nome #
Phthalates and heavy metals as endocrine disruptors in food: A study on pre-packed coffee products 404
A Randomized Trial of Pharmacogenetic Warfarin Dosing in Naive Patients with Non-Valvular Atrial Fibrillation 244
von Willebrand factor propeptide makes it easy to identify the shorter von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease. 220
Sublingual Administration of Sildenafil Oro-dispersible Film: New Profiles of Drug Tolerability and Pharmacokinetics for PDE5 Inhibitors 204
Monitoring Plasma Levels of Donepezil, 5-O-Desmethyl-Donepezil, 6-O-Desmethyl-Donepezil, and Donepezil-N-Oxide by a Novel HPLC Method in Patients with Alzheimer Disease 201
A case of resistance to clopidogrel and prasugrel after percutaneous coronary angioplasty. 197
DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-Register 190
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable? 189
Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms 188
Donepezil plasma concentrations, CYP2D6 and CYP3A4 phenotypes, and cognitive outcome in Alzheimer’s disease 187
R-warfarin anticoagulant effect 187
Perioperative Analgesic Efficacy and Plasma Concentrations of S(+)-Ketamine in Continuous Epidural Infusion During Thoracic Surgery. 177
Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial 177
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study 172
Type 1 von Willebrand disease due to reduced von Willebrand factor synthesis and/or survival: observations from a case series. 171
Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism 170
Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil 169
VERAPAMIL AND NORVERAPAMIL PLASMA-LEVELS IN INFANTS AND CHILDREN DURING CHRONIC ORAL TREATMENT 168
A pharmacokinetic-pharmacodynamic model for individualisation of an oral anticoagulation therapy 168
Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. 166
Pharmacokinetics of Pentoxifylline and Its Main Metabolites in Patients With Different Degrees of Heart Failure Following a Single Dose of a Modified-Release Formulation 166
Combinations of Polymorphisms in Genes Involved in the 5-Fluorouracil Metabolism Pathway Are Associated with Gastrointestinal Toxicity in Chemotherapy-Treated Colorectal Cancer Patients 163
A model-based support for diagnosing von Willebrand disease 162
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 159
Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders 158
Ranolazine-Induced Severe Bladder Hypotonia 157
Reduced survival of type 2B von Willebrand factor, irrespective of large multimer representation or thrombocytopenia. 157
A model-based approach to the automatic diagnosis of von Willebrand disease 156
Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes 154
A Mechanistic Model to Quantify von Willebrand Factor Release, Survival and Proteolysis in Patients with von Willebrand Disease 153
Effect of CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function 148
Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours 147
Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world 147
AJMALINE TEST IN A PATIENT WITH CHRONIC-RENAL-FAILURE - A PHARMACOKINETIC AND PHARMACODYNAMIC STUDY 146
Adaptation of the QT interval to heart rate changes in isolated perfused guinea-pig heart: influence of amiodarone and d-sotalol. 146
Pentoxifylline and its major oxidative metabolites exhibit different pharmacological properties 143
A pharmacometric model describing the relationship between warfarin dose and INR response with respect to variations in CYP2C9, VKORC1, and age 142
Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70 years old 142
Verapamil and norverapamil plasma levels in infants and children during chronic oral treatment 141
Classification of thymidylate synthase gene enhancer region polymorphisms 139
Effects of phospholipase C on the electrical and mechanical activity of guinea pig taenia coli. 139
Towards model-based diagnosis of von Willebrand disease 138
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 137
A model-based protocol for the diagnosis of von Willebrand disease 136
Antiarrhythmic drug plasma concentrations in ambulatory patients 134
Identifying type Vicenza von Willebrand disease 132
Myocardial region (right or left ventricle) and aetiology of heart failure can influence the inotropic effect of ouabain in failing human myocardium 131
Plasma levels and myocardial content of verapamil, norverapamil and two N-dealkyl-metabolites in man 131
DETERMINATION OF LORAJMINE AND ITS METABOLITE AJMALINE IN PLASMA AND URINE BY A NEW HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD 129
Effect of dobutamine on left ventricular relaxation and filling phase in patients with ischemic heart disease and preserved systolic function 129
A novel G/C single-nucleotide polymorphism in the double 28-bp repeat thymidylate synthase allele 127
VKORC1, CYP2C9 AND CYP4F2 GENETIC BASED ALGORITHM FOR WARFARIN DOSING. PRELIMINARY RESULTS OF A PROSPECTIVE ITALIAN STUDY 126
UNDULY ENHANCED RESPONSE TO TOLVAPTAN IN A WOMAN SHOWING SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION: AN INVESTIGATION OF POSSIBLE CAUSES 126
Frequency of uridine monophosphate synthase Gly(213)Ala polymorphism in Caucasian gastrointestinal cancer patients and healthy subjects, investigated by means of new, rapid genotyping assays 125
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. 125
EFFECTS OF PINACIDIL ON GUINEA-PIG ISOLATED PERFUSED HEART WITH PARTICULAR REFERENCE TO THE PROARRHYTHMIC EFFECT 124
Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer. 123
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 123
Digitalis glycosides and plasma renin activity 123
Pharmacokinetic and demographic markers of 5-fluorouracil toxicity in 181 patients on adjuvant therapy for colorectal cancer 123
A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor 123
A PK-PD model for predicting the impact of age, CYP2C9, and VKORC1 genotype on individualization of warfarin therapy 122
Neurohumoral effects of digitalis 119
Population differences in S-warfarin pharmacokinetics among African Americans, Asians and whites: their influence on pharmacogenetic dosing algorithms 119
EFFECTS OF PINACIDIL IN ISOLATED PERFUSED GUINEA-PIG HEART 118
Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction 118
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 117
Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure 117
Ibuprofen enantiomers in premature neonates with patent ductus arteriosus: Preliminary data on an unexpected pharmacokinetic profile of S(+)-ibuprofen 117
Once per week oral administration of amiodarone in the prophylaxis of supraventricular paroxysmal tachycardia 116
Long-term persistence of antianginal effect of oral verapamil in chronic stable angina 115
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 113
Correlations between the enantio- and regio-selective metabolisms of warfarin 113
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 112
Convective and adsorptive removal of β2-microglobulin during predilutional and postdilutional hemofiltration 112
Effect of hemodialysis on the metabolic clearance of 5-Fluorouracil in a patient with end-stage renal failure. Ther Drug Monit. 2005 Dec;27(6):816-8. 111
Apolipoprotein E (APOE) and warfarin dosing in an Italian population. 110
Determination of inulin clearance by bolus intravenous injection in healthy subjects and ascitic patients: equivalence of systemic and renal clearances as glomerular filtration markers 109
Renal excretion and diuretic effect of furosemide in patients with ascitic liver cirrhosis 109
[Anti-arrhythmia drugs of the '80s: something new with respect for the old]. 107
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer 106
Effects of cardiopulmonary bypass on vancomycin plasma concentration decay. 106
Present and future trends in research and clinical applications of inodilators. 106
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 105
A report on the positive inotropic action of amrinone 103
INHIBITORY EFFECT OF BERBERINE ON AGONIST-INDUCED CONTRACTION OF GUINEA-PIG AORTIC STRIPS 103
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer 101
Pharmacokinetics of lidocaine after bilateral ESP block 100
Amiodarone and amiodarone plus digitalis in the treatment of paroxismal supraventricular reciprocatine tachyarrhythmias 100
FARMACOLOGIA CLINICA DELL'IPERTENSIONE ARTERIOSA 99
Twenty four-hour continuous indirect blood pressure monitoring during treatment with slow release metoprolol and atenolol 99
[New inotropic drugs]. 99
Vasorelaxant effects of norbormide, a selective vasospastic agent for the rat microvasculature 99
The association of polymorphisms in 5-fluorouracil metabolism genes with outcome in adjuvant treatment of colorectal cancer 99
The calcium-channel blocker, Verapamil, does not improve portal pressure in patients with alco¬holic cirrhosis. 98
Intralesional topotecan in advanced ovarian cancer: A clinical report, based on a preclinical study 97
Vasorelaxant effect of norbormide, a selective vasoconstrictor of rat microvasculature. 94
CYP2C9 and oral anticoagulation therapy with acenocoumarol and warfarin: similarities yet differences 93
Algebraic decomposition of the TU wave morphology patterns 93
VKORC1, CYP2C9 and CYP4F2 pharmacogenetics: relevance in warfarin maintenance dose prediction among italian patients. 92
Totale 13.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 61.250
article - articoli 53.048
book - libri 249
conference - conferenze 0
curatela - curatele 0
other - altro 188
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.476
Totale 117.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.412 0 0 0 0 47 175 51 170 287 200 223 259
2021/20221.959 61 301 184 157 79 120 71 208 91 39 213 435
2022/20231.677 381 155 26 181 287 237 10 109 211 9 63 8
2023/2024651 31 121 93 60 38 37 32 17 18 15 102 87
2024/20253.452 9 280 172 160 528 74 116 252 258 150 660 793
2025/20265.340 412 1.155 1.826 1.887 60 0 0 0 0 0 0 0
Totale 19.934